ArticleCancer chemotherapy and pharmacology2022

A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.

Antoinette R Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.